Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
NCT07009860

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Led by Altimmune, Inc. · Updated on 2026-03-20

100

Participants Needed

43

Research Sites

115 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly

CONDITIONS

Official Title

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female ages 18 to 75 years, inclusive
  • Overweight or obesity, defined as BMI 25 25 kg/m2
  • History of alcohol misuse for the prior 3 years, with an alcohol intake 25 50 grams per day for males and 25 40 grams per day for females on average in the past year
  • Liver stiffness of 10.0-18.5 kPa by VCTE, inclusive
Not Eligible

You will not qualify if you...

  • Presence of clinically significant alcohol withdrawal symptoms, defined as CIWA-Ar score 25 10 at screening and/or prior to randomization
  • History of hospitalization for alcohol intoxication or alcohol withdrawal within the past year
  • History of seizures related to alcohol within the past year
  • History and/or current DSM-5 diagnosis of schizophrenia, bipolar disorder, psychotic disorder, or another severe psychiatric disorder, unless documented as well-controlled by the Investigator for at least 6 months prior to screening and cleared by the Medical Monitor

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 43 locations

1

Altimmune Clinical Study Site

Peoria, Arizona, United States, 85381

Not Yet Recruiting

2

Altimmune Clinical Study Site

Tucson, Arizona, United States, 85712

Not Yet Recruiting

3

Altimmune Clinical Study Site

Tuscon, Arizona, United States, 85712

Not Yet Recruiting

4

Altimmune Clinical Study Site

North Little Rock, Arkansas, United States, 72117

Actively Recruiting

5

Altimmune Clinical Study Site

Fresno, California, United States, 93720

Not Yet Recruiting

6

Altimmune Clinical Study Site

La Jolla, California, United States, 92037

Not Yet Recruiting

7

Altimmune Clinical Study Site

Pasadena, California, United States, 91105

Not Yet Recruiting

8

Altimmune Clinical Study Site

Englewood, Colorado, United States, 80113

Not Yet Recruiting

9

Altimmune Clinical Study Site

Bradenton, Florida, United States, 34201

Not Yet Recruiting

10

Altimmune Clinical Study Site

Doral, Florida, United States, 33122

Not Yet Recruiting

11

Altimmune Clinical Study Site

Doral, Florida, United States, 33122

Actively Recruiting

12

Altimmune Clinical Study Site

Fort Myers, Florida, United States, 33192

Not Yet Recruiting

13

Altimmune Clinical Study Site

Miami, Florida, United States, 33125

Actively Recruiting

14

Altimmune Clinical Study Site

Miami, Florida, United States, 33165

Not Yet Recruiting

15

Altimmune Clinical Study Site

Miami Lakes, Florida, United States, 33122

Not Yet Recruiting

16

Altimmune Clinical Study Site

Naples, Florida, United States, 34102

Not Yet Recruiting

17

Altimmune Clinical Study Site

Orlando, Florida, United States, 32803

Not Yet Recruiting

18

Altimmune Clinical Study Site

Port Orange, Florida, United States, 32127

Not Yet Recruiting

19

Altimmune Clinical Study Site

Atlanta, Georgia, United States, 30309

Not Yet Recruiting

20

Altimmune Clinical Study Site

Indianapolis, Indiana, United States, 46202

Not Yet Recruiting

21

Altimmune Clinical Study Site

Louisville, Kentucky, United States, 40202

Not Yet Recruiting

22

Altimmune Clinical Study Site

Bastrop, Louisiana, United States, 71220

Not Yet Recruiting

23

Altimmune Clinical Study Site

Marrero, Louisiana, United States, 70072

Not Yet Recruiting

24

Altimmune Clinical Study Site

West Monroe, Louisiana, United States, 71291

Not Yet Recruiting

25

Altimmune Clinical Study Site

Kansas City, Missouri, United States, 64131

Not Yet Recruiting

26

Altimmune Clinical Study Site

St Louis, Missouri, United States, 63123

Actively Recruiting

27

Altimmune Clinical Study Site

Las Vegas, Nevada, United States, 89106

Not Yet Recruiting

28

Altimmune Clinical Study Site

Manhasset, New York, United States, 11030

Not Yet Recruiting

29

Altimmune Clinical Study Site

New York, New York, United States, 10032

Actively Recruiting

30

Altimmune Clinical Study Site

Syracuse, New York, United States, 13210

Actively Recruiting

31

Altimmune Clinical Study Site

Wilmington, North Carolina, United States, 28403

Not Yet Recruiting

32

Altimmune Clinical Study Site

Westlake, Ohio, United States, 44145

Not Yet Recruiting

33

Altimmune Clinical Study Site

Brownsville, Texas, United States, 78520

Not Yet Recruiting

34

Altimmune Clinical Study Site

Dallas, Texas, United States, 75390

Not Yet Recruiting

35

Altimmune Clinical Study Site

Edinburg, Texas, United States, 78539

Not Yet Recruiting

36

Altimmune Clinical Study Site

Houston, Texas, United States, 77030

Not Yet Recruiting

37

Altimmune Clinical Study Site

Houston, Texas, United States, 77079

Not Yet Recruiting

38

Altimmune Clinical Study Site

San Antonio, Texas, United States, 78215

Actively Recruiting

39

Altimmune Clinical Study Site

San Antonio, Texas, United States, 78251

Actively Recruiting

40

Altimmune Clinical Study Site

Waco, Texas, United States, 76710

Not Yet Recruiting

41

Altimmune Clinical Study Site

Richmond, Virginia, United States, 23249

Not Yet Recruiting

42

Altimmune Clinical Study Site

Seattle, Washington, United States, 98105

Not Yet Recruiting

43

Altimmune Clinical Study Site

San Juan, Puerto Rico, Puerto Rico, 00927

Not Yet Recruiting

Loading map...

Research Team

Y

Yadira Ulrey, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here